Cobo Amelia, Vázquez Luis A, Reviriego Jesús, Rodríguez-Mañas Leocadio
Lilly S.A., Alcobendas, Madrid, Spain.
Lilly S.A., Alcobendas, Madrid, Spain.
Endocrinol Nutr. 2016 Jun-Jul;63(6):291-303. doi: 10.1016/j.endonu.2016.01.004. Epub 2016 Mar 9.
Diabetes and frailty are two conditions that frequently occur concurrently and are increasingly prevalent in the older patient. We review the concept, epidemiology and consequences of frailty, and the implications of the presence of frailty in the management of diabetes. Frailty is associated with decreased quality of life, a risk of falls, new or increased disability, hospitalization, and increased mortality. All of these factors affect the management of diabetes in older patients. It is important to rule out frailty in all diabetic patients aged >70 years; if frailty is suspected, a comprehensive and multidisciplinary medical and functional assessment of the patient should be conducted to develop an individualized treatment plan. This plan should include nutritional measures, physical activity, and education on self-care and diabetes; drugs should not be used without a clear indication. Antihyperglycemic drugs that may cause excessive weight loss and/or are associated with a high risk of hypoglycemia should be avoided.
糖尿病和衰弱是两种经常同时出现且在老年患者中日益普遍的病症。我们回顾了衰弱的概念、流行病学及后果,以及衰弱的存在对糖尿病管理的影响。衰弱与生活质量下降、跌倒风险、新的或加重的残疾、住院及死亡率增加有关。所有这些因素都会影响老年糖尿病患者的管理。对所有年龄大于70岁的糖尿病患者进行衰弱筛查很重要;如果怀疑有衰弱,应针对患者进行全面的多学科医学和功能评估,以制定个性化的治疗方案。该方案应包括营养措施、体育活动以及自我护理和糖尿病教育;无明确指征时不应使用药物。应避免使用可能导致体重过度减轻和/或低血糖风险高的降糖药物。